COLUCID PHARMACEUTICALS, INC.
CIK 0001348649
Revenue (TTM)
—
Q3 Nov 2016
Net Income (TTM)
−$50.94M
−940.9% YoY
Q3 Nov 2016
EPS Diluted (TTM)
—
Q3 Nov 2016
Gross Margin
—
Q3 Nov 2016
Operating Margin
—
Q3 Nov 2016
Net Margin
—
Q3 Nov 2016
Free Cash Flow (TTM)
—
Q3 Nov 2016
Cash
$83.54M
Q3 Nov 2016
Total Debt
—
Q3 Nov 2016
Shares Outstanding
19.25M sh
Q3 Nov 2016
Revenue & Net Income
Revenue Growth (YoY)
No data available for this metric.